M esial temporal lobe epilepsy (TLE) with hippocampal sclerosis (MTLE-HS) is one of the most important surgically amenable epilepsies for medically intractable epilepsy patients. 19,23 Long-term seizure freedom after temporal lobe resection has been reported to be approximately 65%. 8,21 Despite significant advances in the surgical procedure and the identification of surgical candidates, approximately 20%-30% of TLE patients continue to have seizures after conventional surgery. Moreover, the probability of seizure freedom 10 years after TLE surgery is reported to range between 40% and 50%.
11Several explanations have been proffered for these surgical failures, including incomplete resection of epileptogenic structures, generation or reactivation of new epileptogenic foci, a dual pathology, or, possibly, surgical ABBREVIATIONS AED = antiepileptic drug; ATL = anterior temporal lobectomy; ATL-AH = ATL with amygdalohippocampectomy; EEG = electroencephalography; GKRS = Gamma Knife radiosurgery; MTLE = mesial temporal lobe epilepsy; MTLE-HS = MTLE hippocampal sclerosis; TLE = temporal lobe epilepsy. SUBMITTED June 9, 2014. ACCEPTED December 18, 2014. INCLUDE WHEN CITING Published online July 10, 2015; DOI: 10.3171/2014.12.JNS141280. DISCLOSURE The authors report no conflict of interest concerning the materials or methods used in this study or the findings specified in this paper. They confirm that they have read the Journal's position on issues involved in ethical publication and affirm that this report is consistent with those guidelines. » This article has been updated from its originally published version to correct the affiliations. See the corresponding erratum notice; DOI: OBJECT Gamma Knife radiosurgery (GKRS) has proven efficacy in the treatment of drug-resistant mesial temporal lobe epilepsy with hippocampal sclerosis (MTLE-HS) and is comparable to conventional resective surgery. It may be effective as an alternative treatment to reoperation after failed temporal lobe surgery in patients with MTLE-HS. The purpose of this study was to investigate the efficacy of GKRS in patients with unilateral MTLE-HS who did not achieve seizure control or had recurrent seizures after anterior temporal lobectomy (ATL). METHODS Twelve patients (8 males; mean age 35.50 ± 9.90 years) with MTLE-HS who underwent GKRS after failed ATL (Engel Classes III-IV) were included. GKRS targets included the remnant tissue or adjacent regions of the previously performed ATL with a marginal dose of 24-25 Gy at the 50% isodose line in all patients. Final seizure outcome was assessed using Engel's modified criteria during the final 2 years preceding data analysis. A comparison between signal changes on follow-up MRI and clinical outcome was performed. RESULTS All patients were followed up for at least 4 years with a mean duration of 6.18 ± 1.77 years (range 4-8.8 years) after GKRS. At the final assessment, 6 of 12 patients were classified as seizure free (Engel Class Ia, n = 3; Ic, n = 2; and Id, n = 1) and 6 patients were classified as not seiz...